3-hydroxy-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one | 123632-32-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: 3-hydroxy-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one
• 英文别名: oxazepam；3-Hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on；1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on；3-Hydroxy-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one；3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
• CAS: 123632-32-6
• 化学式: C₁₅H₁₂N₂O₂
• 分子量: 252.272
• InChiKey: AOKGQOYNOXSOLF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  61.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-hydroxy-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 18.5h， 生成 3-methylamino-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one
  参考文献：
  名称：

  1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus

  摘要：

  Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as a serious threat to patient groups with poorly functioning immune systems. Our approach to finding a novel inhibitor of this virus was to screen a 20 000-member diverse library in a whole cell XTT assay. Parallel assays were carried out in the absence of virus in order to quantify any associated cell toxicity. This identified 100 compounds with IC50's less than 50 mu M. A-33903 (18), a 1,4-benzodiazepine analogue, was chosen as the starting point for lead optimization. This molecule was moderately active and demonstrated good pharmacokinetic properties. The most potent compounds identified from this work were A-58568 (47), A-58569 (44), and A-62066 (46), where modifications to the aromatic substitution enhanced potency, and A-58175 (42), where the amide linker was modified.

  DOI：

  10.1021/jm051185t
• 作为产物：
  描述：

  1,3-二氢-5-苯基-1,4-苯并二氮杂卓-2-酮 在 sodium hydroxide 、 间氯过氧苯甲酸 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 23.0h， 生成 3-hydroxy-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one
  参考文献：
  名称：

  1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus

  摘要：

  Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as a serious threat to patient groups with poorly functioning immune systems. Our approach to finding a novel inhibitor of this virus was to screen a 20 000-member diverse library in a whole cell XTT assay. Parallel assays were carried out in the absence of virus in order to quantify any associated cell toxicity. This identified 100 compounds with IC50's less than 50 mu M. A-33903 (18), a 1,4-benzodiazepine analogue, was chosen as the starting point for lead optimization. This molecule was moderately active and demonstrated good pharmacokinetic properties. The most potent compounds identified from this work were A-58568 (47), A-58569 (44), and A-62066 (46), where modifications to the aromatic substitution enhanced potency, and A-58175 (42), where the amide linker was modified.

  DOI：

  10.1021/jm051185t

文献信息

• FACILE PREPARATION OF 4-SUBSTITUTED QUINAZOLINES AND RELATED HETEROCYCLES
  申请人：Wang Zerong Daniel

  公开号：US20120283436A1

  公开（公告）日：2012-11-08

  A straightforward single step method for the preparation and/or production of substituted quinazolines is disclosed, wherein said quinazolines preferably contain one substituent at position 4, and may contain other functional groups at various positions, such as 5, 6, 7, and/or 8 of quinazolines. In addition, the extension of this new method leads to the formation of different type of heterocyclic aromatic compounds, that include but are not limited to perimidines, anthrapyrimidin-7-ones (also known as anthrapyrimidinones), anthra[1,9:5,10]dipyrimidines (also known as quinazoline[5,4-ef]perimidines) and benzo[e]-pyrimido[4,5,6-gh]pyrimidines.

  本发明揭示了一种制备和/或生产取代喹唑啉的简单单步方法，其中所述喹唑啉优选在位置4处含有一个取代基，并且可能在喹唑啉的各种位置，例如5、6、7和/或8处含有其他官能团。此外，这种新方法的扩展还导致不同类型的杂环芳香化合物的形成，包括但不限于咪唑啉、蒽吡咯啉-7-酮（也称为蒽吡咯啉酮）、蒽[1,9:5,10]二咪唑啉（也称为喹唑啉[5,4-ef]咪唑啉）和苯并[e]-嘧啶[4,5,6-gh]嘧啶。
• Methods of antagonizing CCK or gastrin with benzodiazepine analogs
  申请人：Merck & Co., Inc.

  公开号：US05004741A1

  公开（公告）日：1991-04-02

  Methods of antagonizing gastrin and/or cholecystokinin (CCK) with benzodiazepine analogs are disclosed, as well as related pharmaceutical compositions, which are useful in treating disorders of the gastrointestinal tract, central nervous system, and of the appetite.

  本发明揭示了一种使用苯二氮平类似物拮抗胃泌素和/或胆囊收缩素（CCK）的方法，以及相关的制药组合物，这些组合物对治疗胃肠道、中枢神经系统和食欲障碍有用。
• Benzodiazepine analogs
  申请人：Merck & Co., Inc.

  公开号：US04820834A1

  公开（公告）日：1989-04-11

  Benzodiazepine analogs of the formula: ##STR1## are disclosed which are antagonists of gastrin and cholecystokinin (CCK).

  本文披露了公式为##STR1##的苯二氮平类似物，其为胃泌素和胆囊收缩素（CCK）的拮抗剂。
• Facile preparation of 4-substituted quinazolines and related heterocycles
  申请人：Wang Zerong Daniel

  公开号：US09273012B2

  公开（公告）日：2016-03-01

  A straightforward single step method for the preparation and/or production of substituted quinazolines is disclosed, wherein said quinazolines preferably contain one substituent at position 4, and may contain other functional groups at various positions, such as 5, 6, 7, and/or 8 of quinazolines. In addition, the extension of this new method leads to the formation of different type of heterocyclic aromatic compounds, that include but are not limited to perimidines, anthrapyrimidin-7-ones (also known as anthrapyrimidinones), anthra[1,9:5,10]dipyrimidines (also known as quinazoline[5,4-ef]perimidines) and benzo[e]-pyrimido[4,5,6-gh]pyrimidines.

  本发明揭示了一种制备和/或生产取代喹唑啉的简单单步方法，其中所述喹唑啉优选在4号位置含有一种取代基，并且可能在喹唑啉的5、6、7和/或8号位置含有其他官能团。此外，这种新方法的扩展可以导致形成不同类型的杂环芳香化合物，包括但不限于咪唑啉、蒽并咪唑啉-7-酮（也称为蒽并咪唑酮）、蒽[1,9:5,10]二咪唑啉（也称为喹唑啉[5,4-ef]咪唑啉）和苯并[e]-咪唑并[4,5,6-gh]咪唑啉。
• Benzodiazepine derivatives and pharmaceutical compositions containing them
  申请人：Merck & Co., Inc.

  公开号：EP0167919A2

  公开（公告）日：1986-01-15

  Benzodiazepine analogs of the formula: are disclosed which are antagonists of cholecystokinin (CCK).

  式中的苯二氮卓类似物： 公开了胆囊收缩素（CCK）拮抗剂。